Arcutis Biotherapeutics, (Nasdaq: ARQT) Revenue
Biotechnology Research • 
Thousand Oaks, California, United States • 201-500 Employees
Arcutis Biotherapeutics, (Nasdaq: ARQT) revenue & valuation
| Annual revenue | $263,500,000 |
| Revenue per employee | $694,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $843,100,000 |
| Total funding | $250,000,000 |
Company overview
| Headquarters | 2945 Townsgate Rd, Westlake Village, California 91361, US |
| Phone number | +18446926729 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology, Medical Dermatology, Clinical Trials, Inflammation, Commercialization, Drug Development, Immunology, Bioscience, Atopic Dermatitis, Eczema, Plaque Psoriasis, Topical Drugs |
| Founded | 2016 |
| Employees | 201-500 |
| Socials |
Arcutis Biotherapeutics, (Nasdaq: ARQT) Email Formats
Arcutis Biotherapeutics, (Nasdaq: ARQT) uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@arcutis.com), used 50.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@arcutis.com | 50.5% |
{first name}{last name} | johndoe@arcutis.com | 43.7% |
{last name}{last name} | doedoe@arcutis.com | 5.1% |
About Arcutis Biotherapeutics, (Nasdaq: ARQT)
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is an early commercial stage biopharmaceutical company focused on developing and commercializing best-in-class products. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise in the development and commercialization of medical dermatology products, having held key leadership roles at a number of leading dermatology companies and, collectively, has successfully developed more than 50 FDA-approved products. We believe that by leveraging our team’s unique experience and demonstrated expertise to identify, develop and commercialize best-in-class molecules against validated targets, we will be able to develop differentiated products in less time, at lower cost, and at substantially lower risk than other approaches. Arcutis' combination of vision, unmet medical need, experienced management and strategic approach has attracted support from leading investors in the life sciences sector.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Arcutis Biotherapeutics, (Nasdaq: ARQT) has 233 employees across 16 departments.
Departments
Number of employees
Funding Data
Explore Arcutis Biotherapeutics, (Nasdaq: ARQT)'s funding history, including investment rounds, total capital raised, and key backers.
Arcutis Biotherapeutics, (Nasdaq: ARQT) Tech Stack
Discover the technologies and tools that power Arcutis Biotherapeutics, (Nasdaq: ARQT)'s digital infrastructure, from frameworks to analytics platforms.
Security
Form builders
RUM
Video players
JavaScript libraries
Font scripts
Databases
JavaScript libraries
JavaScript libraries
Programming languages
Security
Israel
United Kingdom
China
Finland
NorwayFrequently asked questions
Key Contact at Arcutis Biotherapeutics, (Nasdaq: ARQT)
4.8
40,000 users
